Adam Dorfman
About Adam Dorfman
Adam Dorfman: Vice President, Quality & Technical Operations
Adam Dorfman serves as the Vice President of Quality & Technical Operations at Clene. He has been with the company since 2013, contributing significantly to its growth and operational excellence. In this role, he ensures that all finished pharmaceuticals meet stringent quality standards for Clene’s active clinical trials, demonstrating his deep commitment to maintaining high-quality pharmaceutical products.
Adam Dorfman's Expertise in Nanoparticle Development and Bioanalysis
With over 13 years of experience, Adam Dorfman specializes in nanoparticle development and characterization, specimen bioanalysis, and quality control. He leads Clene's bioanalytical group, which is responsible for analyzing all GLP/GCP tissue and pharmacokinetic specimens collected during pre-clinical and clinical activities. His extensive background in these fields positions him as an expert in ensuring the integrity and quality of pharmaceutical research and development at Clene.
Adam Dorfman: Educational Background
Adam Dorfman holds a Bachelor of Science in Chemical Engineering from The Pennsylvania State University and a Master of Science in Chemical and Biomolecular Engineering from Johns Hopkins University. His educational background provides a strong foundation in engineering principles, which he applies to his leadership role in Quality & Technical Operations at Clene.
Adam Dorfman's Contributions to Clene's Laboratory Processes
Upon joining Clene in 2013, Adam Dorfman was instrumental in establishing a GMP/GLP compliant lab. He developed and implemented Clene’s laboratory informatics system, significantly streamlining manufacturing and quality control processes. These contributions have enhanced Clene's operational efficiency and compliance with industry standards, underscoring his role as a key player in the company's success.